Skip to content

Hamburg Makes FDA’s Case in WSJ

August 2, 2011

In an OpEd published Monday in the Wall Street Journal, Commissioner Hamburg made her case for the U.S. Food & Drug Administration as “America’s innovation agency.”

She argues that:

  • The FDA’s drug and device approval processes instills confidence in American products, which stimulates the economy and creates new jobs
  • The FDA is being responsive to suggestions that the approval processes are overly burdensome, and
  • The agency is “working with the broader scientific community to address issues of scientific uncertainty that slow medical-product development and review”

Comments are closed.